In contrast, the use of HA as a targeting ligand in the albumin nanoparticles, PP-HA-BSA-NPs, significantly improved drug delivery in CD44-expressing triple-negative breast cancer and colorectal cancer cells. This evidence concerns the gene CD44 and colorectal cancer.